Author： Ruiter Rikje Bijl Monique J van Schaik Ron HN Berns Els MJJ Hofman Albert Coebergh Jan-Willem W van Noord Charlotte Visser Loes E Stricker Bruno HCh
Publisher： Future Medicine
ISSN： 1462-2416
Source： Pharmacogenomics, Vol.11, Iss.10, 2010-10, pp. : 1367-1375
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Related content
The CYP2C19*2 genotype predicts tamoxifen treatment outcome in advanced breast cancer patients
By van Schaik Ron HN Kok Marleen Sweep Fred CGJ van Vliet Martin van Fessem Marianne Meijer-van Gelder Marion E Seynaeve Caroline Lindemans Jan Wesseling Jelle Van ‘t Veer Laura J Span Paul N van Laarhoven Hanneke Sleijfer Stefan Foekens John A Linn Sabine C Berns Els MJJ
Pharmacogenomics, Vol. 12, Iss. 8, 2011-08 ,pp. :
Access to resources
Recommend
By Alcazar-González Gregorio Antonio Calderón-Garcidueñas Ana Laura Garza-Rodríguez María Lourdes Rubio-Hernández Gabriela Escorza-Treviño Sergio Olano-Martin Estibaliz Cerda-Flores Ricardo Martín Castruita-Avila Ana Lilia González-Guerrero Juan Francisco le Brun Stéphane Simon-Buela Laureano Barrera-Saldaña Hugo Alberto
Pharmacogenomics, Vol. 14, Iss. 13, 2013-10 ,pp. :
By Dandara Collet Mutowembwa Masimirembwa Collen Magimba Ayoub Sayi Jane Kaaya Sylvia Sommers De K. Snyman J.R. Hasler Julia Anne
European Journal of Clinical Pharmacology, Vol. 57, Iss. 1, 2001-04 ,pp. :
By Wada F Murase K Isomoto H Soda H Takeshima F Omagari K Mizuta Y Tsukamoto K Murata I Kohno S
The Journal of International Medical Research, Vol. 30, Iss. 4, 2002-07 ,pp. :